Maternal concentrations of insulin-like growth factor i and insulin-like growth factor binding protein 1 during pregnancy and birth weight of offspring

American Journal of Epidemiology

Volumn 174, Issue 2, 2011, Pages 129-135

  Åsvold, Bjørn Olav ^a,b   Eskild, Anne ^c   Jenum, Pl A ^d,e   Vatten, Lars J ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e Department of Medical Microbiology   (Norway)

Author keywords

birth weight; insulin like growth factor binding protein 1; insulin like growth factor I; Norway; pregnancy

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

GROWTH; HORMONE; HYPERTENSION; PREGNANCY; PROTEIN; WEIGHT;

ADULT; ARTICLE; BIRTH WEIGHT; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN EXPERIMENT; LIVE BIRTH; LOW BIRTH WEIGHT; NEWBORN; PREGNANCY; PROGENY; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY;

ADULT; BIRTH WEIGHT; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; NORWAY; PREGNANCY;

NORWAY;

EID: 79960537866     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr067     Document Type: Article

References (32)

1. Verhaeghe J, Van Herck E, Billen J, et al. Regulation of insulin-like growth factor-I and insulin-like growth factor binding protein-1 concentrations in preterm fetuses. Am J Obstet Gynecol. 2003;188(2):485-491. (Pubitemid 36249990)
2. Chellakooty M, Vangsgaard K, Larsen T, et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab. 2004;89(1):384-391. (Pubitemid 38183908)
3. Holmes RP, Holly JM, Soothill PW. A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses. Br J Obstet Gynaecol. 1998;105(12):1273-1278. (Pubitemid 29002828)
4. Mirlesse V, Frankenne F, Alsat E, et al. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res. 1993;34(4): 439-442. (Pubitemid 23297171)
5. Hall K, Hansson U, Lundin G, et al. Serum levels of somatomedins and somatomedin-binding protein in pregnant women with type I or gestational diabetes and their infants. J Clin Endocrinol Metab. 1986;63(6):1300-1306. (Pubitemid 17206421)
6. Holmes R, Porter H, Newcomb P, et al. An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses. Placenta. 1999;20(4):325-330. (Pubitemid 29199649)
7. Caufriez A, Frankenne F, Hennen G, et al. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol. 1993;265(4 pt 1): E572-E577.
8. Hills FA, English J, Chard T. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol. 1996;148(2): 303-309. (Pubitemid 26046924)
9. Olausson H, Lof M, Brismar K, et al. Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Horm Res. 2008;69(2):99-106.
10. Wang HS, Lim J, English J, et al. The concentration of insulinlike growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol. 1991;129(3):459-464.
11. Clapp JF III, Schmidt S, Paranjape A, et al. Maternal insulinlike growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass. Am J Obstet Gynecol. 2004;190(3): 730-736. (Pubitemid 38406785)
12. Monaghan JM, Godber IM, Lawson N, et al. Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy. Ann Clin Biochem. 2004;41(pt 3):220-226. (Pubitemid 38623148)
13. Giudice LC, Martina NA, Crystal RA, et al. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol. 1997;176(4):751-757; discussion 757-758.
14. Iwashita M, Kobayashi M, Matsuo A, et al. Feto-maternal interaction of IGF-I and its binding proteins in fetal growth. Early Hum Dev. 1992;29(1-3):187-191.
15. Baldwin S, Chung T, Rogers M, et al. Insulin-like growth factor-binding protein-1, glucose tolerance and fetal growth in human pregnancy. J Endocrinol. 1993;136(2):319-325. (Pubitemid 23142194)
16. Boyne MS, Thame M, Bennett FI, et al. The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and-2, and birth anthropometry: a prospective study. J Clin Endocrinol Metab. 2003;88(4): 1687-1691. (Pubitemid 36623389)
17. Fowler D, Albaiges G, Lees C, et al. The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound. Hum Reprod. 1999;14(11):2881-2885. (Pubitemid 29520712)
18. Gibson JM, Westwood M, Lauszus FF, et al. Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects. Diabetes. 1999;48(2):321-326. (Pubitemid 29061105)
19. Langford K, Blum W, Nicolaides K, et al. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by undernutrition? Eur J Clin Invest. 1994;24(12):851-856. (Pubitemid 24374783)
20. Bhatia S, Faessen GH, Carland G, et al. A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-I) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab. 2002;87(4):1864-1870. (Pubitemid 34615281)
21. Qiu C, Vadachkoria S, Meryman L, et al. Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus. Am J Obstet Gynecol. 2005;193(5):1691-1697. (Pubitemid 41540468)
22. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58(2): 453-459.
23. Murphy LJ. The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. Exp Diabesity Res. 2003;4(4):213-224. (Pubitemid 38035563)
24. Olausson H, Löf M, Brismar K, et al. Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight. Br J Nutr. 2010;104(6):842-848.
25. Jenum PA, Stray-Pedersen B, Melby KK, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol. 1998;36(10):2900-2906. (Pubitemid 28429412)
26. Eskild A, Jenum PA, Bruu AL. Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight. Acta Obstet Gynecol Scand. 2005;84(11): 1035-1041. (Pubitemid 41564525)
27. Vatten LJ, Eskild A, Nilsen TI, et al. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007; 196(3):239. e1-239.e6.
28. Vatten LJ, Nilsen TI, Juul A, et al. Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol. 2008;158(1):101-105. (Pubitemid 351211046)
29. Skjaerven R, Gjessing HK, Bakketeig LS. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand. 2000; 79(6):440-449. (Pubitemid 30326124)
30. Larsen T, Main K, Andersson AM, et al. Growth hormone, insulin-like growth factor I and its binding proteins 1 and 3 in last trimester intrauterine growth retardation with increased pulsatility index in the umbilical artery. Clin Endocrinol (Oxf). 1996;45(3):315-319. (Pubitemid 26306700)
31. Martina NA, Kim E, Chitkara U, et al. Gestational agedependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab. 1997;82(6): 1894-1898. (Pubitemid 127495206)
32. Verhaeghe J, Billen J, Giudice LC. Insulin-like growth factorbinding protein-1 in umbilical artery and vein of term fetuses with signs suggestive of distress during labor. J Endocrinol. 2001;170(3):585-590. (Pubitemid 32834324)